Hemophilia Drug Hits Mark in Trial

(MedPage Today) -- A coagulation factor replacement therapy for hemophilia B met its primary efficacy and safety objectives in a phase III trial, its developers said. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/09/hemophilia-drug-hits-mark-in-trial.html